MDXH · MDxHealth SA · Metrics
Market Cap
$67.23M
Shares
95.42M
MDXH metrics
46 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$0.70
Market cap
$67.23M
Price action
20 metricsPrice change (1W)
-6.9%
Price change (30D)
+46.3%
Price change (3M)
+15.2%
Price change (6M)
-79.2%
Price change (YTD)
-81.1%
Price change (1Y)
-80.6%
Trailing year
Price change (5Y)
—
52-week high
$5.00
52-week low
$0.40
Change from 52-week high
-86.5%
Change from 52-week low
+69.0%
Annualized volatility
113.8%
Annualized volatility (3M)
172.7%
Beta
1.8
RSI (14D)
51.6
Price vs SMA 50
+21.5%
Price vs SMA 200
-67.1%
Avg volume (3M)
5.96M
Relative volume
0.1
Average dollar volume
$4.65M
Company
3 metricsSector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
95.42M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-03-31
Profitability
9 metricsGross margin
64.5%
Operating margin
-13.4%
Trailing 12 months
Net margin
-31.1%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+19.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.8%
Year over year · more shares
Revenue CAGR (3Y)
+42.8%
Revenue CAGR (5Y)
+42.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-22.7%
Debt / equity
—
Current ratio
1.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$29.03M
Total assets
$147.95M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
26
13F filer change QoQ
-26
Institutional ownership
17.4%
Short interest
3 metricsShort interest
1.6%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
40 / 100
Insider activity
2 metricsNet insider buying (90D)
$1,000,000
Insider-sentiment score
89 / 100
Risk flags
1 metricsGoing concern
—